Top Markets
#1 Bedrock Bedrock +63.94%
#2 Naoris Protocol Naoris Protocol +27.19%
#3 DeFiChain DeFiChain +19.69%
#4 pippin pippin +19.33%
#5 ETHGas ETHGas +19.23%
#6 Irys Irys +15.80%
#7 IQ IQ +14.90%
#8 DUSK Network DUSK Network +14.06%
#9 Amiko Amiko +12.81%
#10 Magma Finance Magma Finance +11.91%
Coin of the day
Bedrock Bedrock
Settings
Language
ENGLISH
Currency
USD
Theme
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Rank in Stocks #47
Merck & Co., Inc. operates as a healthcare company worldwide. It operates... Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Share Price
$115.67
Market Cap
$285.98B
Change (1 day)
1.30%
Change (1 year)
25.31%
Country
US
Trade Merck & Co., Inc. (MRK)

Category

Healthcare
Number of shares outstanding for Merck & Co., Inc. (MRK)
Number of shares outstanding as of December 2025: 2.49B
According to Merck & Co., Inc. latest financial reports and stock price the company's current number of shares outstanding is 2.49B. At the end of December 2024 the company had 2.53B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Merck & Co., Inc. (MRK) from 2000 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 2.49B -0.70%
2025 2.51B -0.97%
2024 2.53B -2.88%
2023 2.61B 2.97%
2022 2.53B 0.08%
2021 2.53B 0.00%
2020 2.53B -1.36%
2019 2.57B -1.06%
2018 2.59B -3.86%
2017 2.70B -1.90%
2016 2.75B -1.16%
2015 2.78B -2.01%
2014 2.84B -3.05%
2013 2.93B -3.27%
2012 3.03B -0.47%
2011 3.04B -1.75%
2010 3.10B 46.79%
2009 2.11B -1.29%
2008 2.14B -1.59%
2007 2.17B -0.33%
2006 2.18B -0.88%
2005 2.20B -0.99%
2004 2.22B -0.79%
2003 2.24B -0.92%
2002 2.26B -1.35%
2001 2.29B -0.81%
2000 2.31B 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 898.00M -63.93%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 3.10B 24.50%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.43B -2.46%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.78B -28.50%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 1.91B -23.17%
CH